Discover ITM and its cancer candidate ITM-11 as it brings one of the first big wins the radiopharmaceutical sector awaits.

JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company with a market capitalization of $40.39 million, has announced a strategic partnership with Zina ...

Dynatrace today announced extended capabilities for the observability of customers' GenAI initiatives. These advancements provide teams with access to comprehensive insights into their AI applications ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based biotech firm with a market capitalization of $13.24 million, revealed promising results from a recent pre-pivotal clinical trial for its ...

Pakistan's plan of defeating West Indies with 'trial by spin' backfired massively in Multan. Pakistan were reduced to 76/4 at ...

This is an audio transcript of the Unhedged podcast episode: ‘Decoding Trumponomics’ Katie Martin He’s back and he’s busy.

Jennings played the last of his three BBL games on December 23, while Hurst made it until January 3 before Perth ran out of patience ... James Vince became the second import in BBL history to surpass ...

A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...

is being evaluated in two phase 3 trials, SOL-1 and SOL-R, for the treatment of wet age-related macular degeneration. Kaiser shared data from the phase 1 HELIOS trial that showed stability or ...